Invest in startups from as little as € 250 with the new minimum investment amount.

Simple - digital - fast.

REFINED DIAGNOSTICS

Breakthrough in cancer diagnostics: Nobel Prize-winning technology enables precise diagnoses in minutes.

€ 2,805,050

Invested

124

Investors

Funding Goal

€ 2,900,000

Minimum investment

€ 250

Company Valuation

€ 13,000,000

Mediator

Companisto Wertpapier GmbH

Co-Investors

APEX Ventures, High-Tech Gründerfonds, NRW.Bank, Onsight Ventures, existing and new business angels

We are close to funding goal!

€ 2,805,050

€ 2,900,000

Summary

Invest now

More Startups

Legal notice: The acquisition of this security is associated with considerable risks and can lead to the complete loss of the invested assets. The expected return is not guaranteed and may be lower than expected.

Documents

Balance Sheet 2025

Last Update: 17. March 2026 17. Mar. 2026

Participation documents

Last Update: 17. March 2026 17. Mar. 2026

Note

This document is used to advertise the security. A basic information sheet has been published for this security offer. This can be downloaded from www.companisto-trust-service.de/LVIII/bib. The information about the companies on the Companisto website is provided exclusively by the companies.

To see the full profile of Refined Diagnostics , please register or log in.

Already registered?

Please note

The acquisition of the offered securities and investments is associated with considerable risks and can lead to the complete loss of the invested assets. The expected yield is not guaranteed and may be lower. Whether it is a security or an asset investment can be seen in the description of the investment opportunity.